Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J9226 |
Short Description | Supprelin la implant |
Long Description | Histrelin implant (supprelin la), 50 mg |
Pricing indicator | 51 |
Coverage code | D |
ASC payment group code | YY |
BETOS2 code | O1D |
Action code | P |
Type of service | 1 |
Effective date | 2024-01-01 |
Date Added | 2008-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
67979000201 | J9226 | Supprelin la implant | Supprelin LA implant | ENDO PHARMACEUTICALS VALERA INC. | 50 MG | 1 | 1 | 1 | 1 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 50 MG |
HCPCS/CPT Billing Units | 0.02 |
Total doses ordered | |
Billing Units | 0.02 |
Drug Details
-
Histrelin implant (Vantas) is used to treat the symptoms associated with advanced prostate cancer. Histrelin implant (Supprelin LA) is used to treat central precocious puberty (CPP; a condition causing children to enter puberty too soon, resulting in faster than normal bone growth and development of sexual characteristics) in girls usually between 2 and 8 years of age and in boys usually between 2 and 9 years of age. Histrelin implant is in a class of medications called gonadotropin-releasing hormone (GnRH) agonists. It works by decreasing the amount of certain hormones in the body.